25 XP   0   0   10

Aequus Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Aequus Pharmaceuticals Inc together

PenkeI guess you are interested in Aequus Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Aequus Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Aequus Pharmaceuticals Inc

I send you an email if I find something interesting about Aequus Pharmaceuticals Inc.

Quick analysis of Aequus Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Aequus Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$-0.01
Expected worth in 1 year
C$-0.11
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
C$-0.10
Return On Investment
-637.2%

For what price can you sell your share?

Current Price per Share
C$0.02
Expected price per share
C$0.01 - C$0.02
How sure are you?
50%

1. Valuation of Aequus Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

C$0.02

Intrinsic Value Per Share

C$-0.12 - C$0.04

Total Value Per Share

C$-0.13 - C$0.03

2. Growth of Aequus Pharmaceuticals Inc (5 min.)




Is Aequus Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$1m$1.3m-$2.3m-229.6%

How much money is Aequus Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$2.3m-$1.3m-$1m-43.6%
Net Profit Margin-232.7%-66.7%--

How much money comes from the company's main activities?

3. Financial Health of Aequus Pharmaceuticals Inc (5 min.)




What can you expect buying and holding a share of Aequus Pharmaceuticals Inc? (5 min.)

Welcome investor! Aequus Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Aequus Pharmaceuticals Inc.

What can you expect buying and holding a share of Aequus Pharmaceuticals Inc?

First you should know what it really means to hold a share of Aequus Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Aequus Pharmaceuticals Inc is C$0.015. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aequus Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aequus Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$-0.01. Based on the TTM, the Book Value Change Per Share is C$-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is C$0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aequus Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps-0.02-117.8%-0.02-117.8%-0.01-66.4%-0.01-87.9%-0.02-109.1%
Usd Book Value Change Per Share-0.02-116.3%-0.02-116.3%0.0144.6%0.00-27.0%0.00-5.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-116.3%-0.02-116.3%0.0144.6%0.00-27.0%0.00-5.1%
Usd Price Per Share0.03-0.03-0.08-0.08-0.12-
Price to Earnings Ratio-1.45--1.45--8.43--7.55--6.98-
Price-to-Total Gains Ratio-1.46--1.46-12.55--3.48--213.90-
Price to Book Ratio-3.36--3.36-8.53-5.24-13.06-
Price-to-Total Gains Ratio-1.46--1.46-12.55--3.48--213.90-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0109515
Number of shares91311
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.00
Usd Total Gains Per Share-0.020.00
Gains per Quarter (91311 shares)-1,592.89-370.44
Gains per Year (91311 shares)-6,371.57-1,481.78
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-6372-63820-1482-1492
20-12743-127540-2964-2974
30-19115-191260-4445-4456
40-25486-254980-5927-5938
50-31858-318700-7409-7420
60-38229-382420-8891-8902
70-44601-446140-10372-10384
80-50973-509860-11854-11866
90-57344-573580-13336-13348
100-63716-637300-14818-14830

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.010.00.00.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%2.03.00.040.0%5.05.00.050.0%5.05.00.050.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.010.00.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%2.03.00.040.0%5.05.00.050.0%5.05.00.050.0%

Fundamentals of Aequus Pharmaceuticals Inc

About Aequus Pharmaceuticals Inc

Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.

Fundamental data was last updated by Penke on 2024-04-19 06:40:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Aequus Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Aequus Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Aequus Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -232.7% means that $-2.33 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aequus Pharmaceuticals Inc:

  • The MRQ is -232.7%. The company is making a huge loss. -2
  • The TTM is -232.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-232.7%TTM-232.7%0.0%
TTM-232.7%YOY-66.7%-166.0%
TTM-232.7%5Y-145.7%-86.9%
5Y-145.7%10Y-175.5%+29.8%
1.1.2. Return on Assets

Shows how efficient Aequus Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aequus Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -189.8% Return on Assets means that Aequus Pharmaceuticals Inc generated $-1.90 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aequus Pharmaceuticals Inc:

  • The MRQ is -189.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -189.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-189.8%TTM-189.8%0.0%
TTM-189.8%YOY-41.6%-148.2%
TTM-189.8%5Y-118.2%-71.6%
5Y-118.2%10Y-173.1%+54.9%
1.1.3. Return on Equity

Shows how efficient Aequus Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aequus Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Aequus Pharmaceuticals Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aequus Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-101.1%+101.1%
TTM-5Y-90.0%+90.0%
5Y-90.0%10Y-205.2%+115.2%

1.2. Operating Efficiency of Aequus Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Aequus Pharmaceuticals Inc is operating .

  • Measures how much profit Aequus Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aequus Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -181.0% means the company generated $-1.81  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aequus Pharmaceuticals Inc:

  • The MRQ is -181.0%. The company is operating very inefficient. -2
  • The TTM is -181.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-181.0%TTM-181.0%0.0%
TTM-181.0%YOY-49.9%-131.2%
TTM-181.0%5Y-117.1%-64.0%
5Y-117.1%10Y-162.3%+45.2%
1.2.2. Operating Ratio

Measures how efficient Aequus Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 2.81 means that the operating costs are $2.81 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Aequus Pharmaceuticals Inc:

  • The MRQ is 2.810. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.810. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.810TTM2.8100.000
TTM2.810YOY1.504+1.307
TTM2.8105Y2.173+0.637
5Y2.17310Y2.323-0.150

1.3. Liquidity of Aequus Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Aequus Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.38 means the company has $0.38 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Aequus Pharmaceuticals Inc:

  • The MRQ is 0.380. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.380. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.380TTM0.3800.000
TTM0.380YOY1.462-1.083
TTM0.3805Y3.059-2.679
5Y3.05910Y3.300-0.241
1.3.2. Quick Ratio

Measures if Aequus Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aequus Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.27 means the company can pay off $0.27 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aequus Pharmaceuticals Inc:

  • The MRQ is 0.273. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.273. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.273TTM0.2730.000
TTM0.273YOY1.375-1.101
TTM0.2735Y2.766-2.493
5Y2.76610Y3.072-0.306

1.4. Solvency of Aequus Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Aequus Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aequus Pharmaceuticals Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 1.82 means that Aequus Pharmaceuticals Inc assets are financed with 181.6% credit (debt) and the remaining percentage (100% - 181.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aequus Pharmaceuticals Inc:

  • The MRQ is 1.816. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.816. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.816TTM1.8160.000
TTM1.816YOY0.589+1.227
TTM1.8165Y0.981+0.835
5Y0.98110Y0.625+0.355
1.4.2. Debt to Equity Ratio

Measures if Aequus Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aequus Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aequus Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.430-1.430
TTM-5Y1.216-1.216
5Y1.21610Y0.817+0.398

2. Market Valuation of Aequus Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Aequus Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Aequus Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1.45 means the investor is paying $-1.45 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aequus Pharmaceuticals Inc:

  • The EOD is -0.620. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.446. Based on the earnings, the company is expensive. -2
  • The TTM is -1.446. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.620MRQ-1.446+0.826
MRQ-1.446TTM-1.4460.000
TTM-1.446YOY-8.429+6.983
TTM-1.4465Y-7.554+6.108
5Y-7.55410Y-6.985-0.569
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aequus Pharmaceuticals Inc:

  • The EOD is -1.019. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.377. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.377. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.019MRQ-2.377+1.359
MRQ-2.377TTM-2.3770.000
TTM-2.377YOY-12.967+10.589
TTM-2.3775Y-10.586+8.209
5Y-10.58610Y-8.862-1.724
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Aequus Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Aequus Pharmaceuticals Inc:

  • The EOD is -1.442. Based on the equity, the company is expensive. -2
  • The MRQ is -3.364. Based on the equity, the company is expensive. -2
  • The TTM is -3.364. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.442MRQ-3.364+1.922
MRQ-3.364TTM-3.3640.000
TTM-3.364YOY8.526-11.889
TTM-3.3645Y5.243-8.607
5Y5.24310Y13.063-7.820
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Aequus Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.024-0.0240%0.009-361%-0.006-77%-0.001-96%
Book Value Per Share---0.010-0.0100%0.013-177%0.003-486%0.007-240%
Current Ratio--0.3800.3800%1.462-74%3.059-88%3.300-88%
Debt To Asset Ratio--1.8161.8160%0.589+209%0.981+85%0.625+190%
Debt To Equity Ratio----0%1.430-100%1.216-100%0.817-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.024-0.0240%-0.014-44%-0.018-25%-0.022-7%
Free Cash Flow Per Share---0.015-0.0150%-0.009-40%-0.012-16%-0.018+19%
Free Cash Flow To Equity Per Share---0.016-0.0160%0.009-275%-0.001-97%0.001-2786%
Gross Profit Margin--1.1541.1540%2.065-44%1.777-35%1.459-21%
Intrinsic Value_10Y_max--0.044--------
Intrinsic Value_10Y_min---0.120--------
Intrinsic Value_1Y_max---0.007--------
Intrinsic Value_1Y_min---0.012--------
Intrinsic Value_3Y_max---0.012--------
Intrinsic Value_3Y_min---0.037--------
Intrinsic Value_5Y_max---0.007--------
Intrinsic Value_5Y_min---0.062--------
Market Cap1989510.000-133%4642205.0854642205.0850%15252910.000-70%14589743.017-68%22216196.509-79%
Net Profit Margin---2.327-2.3270%-0.667-71%-1.457-37%-1.755-25%
Operating Margin---1.810-1.8100%-0.499-72%-1.171-35%-1.623-10%
Operating Ratio--2.8102.8100%1.504+87%2.173+29%2.323+21%
Pb Ratio-1.442+57%-3.364-3.3640%8.526-139%5.243-164%13.063-126%
Pe Ratio-0.620+57%-1.446-1.4460%-8.429+483%-7.554+422%-6.985+383%
Price Per Share0.015-133%0.0350.0350%0.115-70%0.110-68%0.168-79%
Price To Free Cash Flow Ratio-1.019+57%-2.377-2.3770%-12.967+445%-10.586+345%-8.862+273%
Price To Total Gains Ratio-0.628+57%-1.465-1.4650%12.553-112%-3.480+138%-213.904+14503%
Quick Ratio--0.2730.2730%1.375-80%2.766-90%3.072-91%
Return On Assets---1.898-1.8980%-0.416-78%-1.182-38%-1.731-9%
Return On Equity----0%-1.0110%-0.9000%-2.0520%
Total Gains Per Share---0.024-0.0240%0.009-361%-0.006-77%-0.001-96%
Usd Book Value---1007565.744-1007565.7440%1306196.357-177%261013.816-486%718774.032-240%
Usd Book Value Change Per Share---0.017-0.0170%0.007-361%-0.004-77%-0.001-96%
Usd Book Value Per Share---0.008-0.0080%0.010-177%0.002-486%0.005-240%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.018-0.0180%-0.010-44%-0.013-25%-0.016-7%
Usd Free Cash Flow---1425577.928-1425577.9280%-858838.533-40%-1191972.796-16%-1700980.774+19%
Usd Free Cash Flow Per Share---0.011-0.0110%-0.006-40%-0.009-16%-0.013+19%
Usd Free Cash Flow To Equity Per Share---0.012-0.0120%0.007-275%0.000-97%0.000-2786%
Usd Market Cap1452541.251-133%3389273.9333389273.9330%11136149.591-70%10651971.377-68%16220045.071-79%
Usd Price Per Share0.011-133%0.0260.0260%0.084-70%0.080-68%0.122-79%
Usd Profit---2343653.124-2343653.1240%-1321183.119-44%-1748566.137-25%-2169944.958-7%
Usd Revenue--1007371.5371007371.5370%1982001.010-49%1420752.259-29%844791.701+19%
Usd Total Gains Per Share---0.017-0.0170%0.007-361%-0.004-77%-0.001-96%
 EOD+2 -6MRQTTM+0 -0YOY+3 -305Y+4 -2910Y+8 -25

3.2. Fundamental Score

Let's check the fundamental score of Aequus Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.620
Price to Book Ratio (EOD)Between0-1-1.442
Net Profit Margin (MRQ)Greater than0-2.327
Operating Margin (MRQ)Greater than0-1.810
Quick Ratio (MRQ)Greater than10.273
Current Ratio (MRQ)Greater than10.380
Debt to Asset Ratio (MRQ)Less than11.816
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.898
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Aequus Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.829
Ma 20Greater thanMa 500.016
Ma 50Greater thanMa 1000.017
Ma 100Greater thanMa 2000.021
OpenGreater thanClose0.015
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Net Working Capital  920-2886321,7522,384-1,2481,136-2,611-1,475



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets1,691
Total Liabilities3,072
Total Stockholder Equity-1,380
 As reported
Total Liabilities 3,072
Total Stockholder Equity+ -1,380
Total Assets = 1,691

Assets

Total Assets1,691
Total Current Assets903
Long-term Assets789
Total Current Assets
Cash And Cash Equivalents 250
Short-term Investments 45
Net Receivables 310
Inventory 94
Other Current Assets 204
Total Current Assets  (as reported)903
Total Current Assets  (calculated)903
+/-0
Long-term Assets
Property Plant Equipment 789
Long-term Assets  (as reported)789
Long-term Assets  (calculated)789
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,378
Long-term Liabilities694
Total Stockholder Equity-1,380
Total Current Liabilities
Short-term Debt 89
Short Long Term Debt 2,000
Accounts payable 88
Other Current Liabilities 2,200
Total Current Liabilities  (as reported)2,378
Total Current Liabilities  (calculated)4,378
+/- 2,000
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt694
Long-term Liabilities  (as reported)694
Long-term Liabilities  (calculated)694
+/-0
Total Stockholder Equity
Common Stock23,991
Retained Earnings -29,720
Accumulated Other Comprehensive Income 4,349
Total Stockholder Equity (as reported)-1,380
Total Stockholder Equity (calculated)-1,380
+/-0
Other
Capital Stock23,991
Cash and Short Term Investments 295
Common Stock Shares Outstanding 132,634
Liabilities and Stockholders Equity 1,691
Net Debt 533
Net Invested Capital 620
Net Working Capital -1,475
Property Plant and Equipment Gross 1,308
Short Long Term Debt Total 783



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
> Total Assets 
337
3,666
2,430
2,010
2,672
1,997
1,673
3,135
4,348
1,691
1,6914,3483,1351,6731,9972,6722,0102,4303,666337
   > Total Current Assets 
331
3,661
1,385
804
1,715
1,235
1,108
2,768
3,593
903
9033,5932,7681,1081,2351,7158041,3853,661331
       Cash And Cash Equivalents 
312
3,576
1,164
473
1,165
370
485
1,719
2,392
250
2502,3921,7194853701,1654731,1643,576312
       Short-term Investments 
0
0
0
0
0
0
0
0
45
45
454500000000
       Net Receivables 
9
75
94
190
430
731
556
780
941
310
31094178055673143019094759
       Other Current Assets 
0
8
52
0
81
121
62
147
120
204
204120147621218105280
   > Long-term Assets 
7
5
1,045
1,207
957
761
565
366
755
789
7897553665657619571,2071,04557
       Property Plant Equipment 
7
5
7
46
35
28
480
366
242
789
789242366480283546757
       Intangible Assets 
0
0
763
1,073
903
733
85
0
0
0
000857339031,07376300
       Other Assets 
0
0
275
88
19
0
0
0
513
0
0513000198827500
> Total Liabilities 
57
745
1,145
744
367
315
2,550
2,561
2,559
3,072
3,0722,5592,5612,5503153677441,14574557
   > Total Current Liabilities 
57
745
1,145
744
367
315
476
384
2,457
2,378
2,3782,4573844763153677441,14574557
       Short-term Debt 
0
0
0
0
0
0
144
147
2,078
89
892,078147144000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
1,927
2,000
2,0001,92700000000
       Accounts payable 
57
617
1,020
705
336
269
250
161
157
88
881571612502693367051,02061757
       Other Current Liabilities 
0
0
0
0
0
46
83
76
222
2,200
2,20022276834600000
   > Long-term Liabilities 
0
0
0
0
0
0
2,074
2,176
102
694
6941022,1762,074000000
> Total Stockholder Equity
281
2,921
1,285
1,266
2,305
1,682
-877
574
1,789
-1,380
-1,3801,789574-8771,6822,3051,2661,2852,921281
   Common Stock
1,195
2,029
7,582
12,607
17,095
18,935
19,083
21,172
23,991
23,991
23,99123,99121,17219,08318,93517,09512,6077,5822,0291,195
   Retained Earnings -29,720-26,509-24,700-23,655-20,550-17,746-13,864-9,052-4,040-1,629
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
4,102
4,308
4,349
4,3494,3084,1020000000
   Capital Surplus 0000000000
   Treasury Stock0000000000



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue1,380
Cost of Revenue-233
Gross Profit1,1461,146
 
Operating Income (+$)
Gross Profit1,146
Operating Expense-3,644
Operating Income-2,498-2,498
 
Operating Expense (+$)
Research Development169
Selling General Administrative2,981
Selling And Marketing Expenses495
Operating Expense3,6443,644
 
Net Interest Income (+$)
Interest Income25
Interest Expense-214
Other Finance Cost-0
Net Interest Income-189
 
Pretax Income (+$)
Operating Income-2,498
Net Interest Income-189
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,210-1,786
EBIT - interestExpense = -2,712
-3,210
-2,996
Interest Expense214
Earnings Before Interest and Taxes (EBIT)-2,498-2,996
Earnings Before Interest and Taxes (EBITDA)-2,368
 
After tax Income (+$)
Income Before Tax-3,210
Tax Provision-0
Net Income From Continuing Ops-3,210-3,210
Net Income-3,210
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,878
Total Other Income/Expenses Net-712189
 

Technical Analysis of Aequus Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Aequus Pharmaceuticals Inc. The general trend of Aequus Pharmaceuticals Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Aequus Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Aequus Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.02 < 0.02 < 0.02.

The bearish price targets are: 0.01 > 0.01 > 0.01.

Tweet this
Aequus Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Aequus Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Aequus Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Aequus Pharmaceuticals Inc. The current macd is -0.00060788.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aequus Pharmaceuticals Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Aequus Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Aequus Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Aequus Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartAequus Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Aequus Pharmaceuticals Inc. The current adx is 15.85.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Aequus Pharmaceuticals Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Aequus Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Aequus Pharmaceuticals Inc. The current sar is 0.01885842.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Aequus Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Aequus Pharmaceuticals Inc. The current rsi is 45.83. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Aequus Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartAequus Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Aequus Pharmaceuticals Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -3/(-6 +6).

  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Aequus Pharmaceuticals Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Aequus Pharmaceuticals Inc Daily Stochastic Oscillator ChartAequus Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Aequus Pharmaceuticals Inc. The current cci is -31.74603175.

Aequus Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartAequus Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Aequus Pharmaceuticals Inc. The current cmo is -10.1637823.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Aequus Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartAequus Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Aequus Pharmaceuticals Inc. The current willr is -50.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Aequus Pharmaceuticals Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Aequus Pharmaceuticals Inc Daily Williams %R ChartAequus Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Aequus Pharmaceuticals Inc.

Aequus Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Aequus Pharmaceuticals Inc. The current atr is 0.00144453.

Aequus Pharmaceuticals Inc Daily Average True Range (ATR) ChartAequus Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Aequus Pharmaceuticals Inc. The current obv is 3,496,908.

Aequus Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartAequus Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Aequus Pharmaceuticals Inc. The current mfi is 97.73.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Aequus Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartAequus Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Aequus Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Aequus Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Aequus Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.829
Ma 20Greater thanMa 500.016
Ma 50Greater thanMa 1000.017
Ma 100Greater thanMa 2000.021
OpenGreater thanClose0.015
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Aequus Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Aequus Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Aequus Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Aequus Pharmaceuticals Inc

I send you an email if I find something interesting about Aequus Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Aequus Pharmaceuticals Inc.

Receive notifications about Aequus Pharmaceuticals Inc in your mailbox!